PBI is a safe and efficacious treatment for subfoveal CNV not due to AMD. The data with respect to visual outcomes and radiation complications trend in favour of the 16 CGE group, although differences do not reach statistical significance. PBI may be considered as an alternative to current therapies …

2014年4月11日 · Answer: Choroidal neovascularization (or CNV) is the growth of abnormal blood vessels beneath the retina. CNV can occur in a variety of conditions, and its effects are sometimes known as choroidal neovascular membranes (CNVM). Age-related macular degeneration is the most common condition CNV occurs with, but it is also seen with others.

This retrospective, cross-sectional study explores the potential advantages of PR-OCTA in evaluating CNV secondary to AMD. First, we compare the PR-OCTA method to the slab subtraction technique for quantitative CNV analysis using en face OCTA.

2025年1月2日 · CNV is most commonly associated with age-related macular degeneration (AMD), but it can also occur in other eye diseases, such as myopic degeneration and ocular inflammatory conditions. Understanding CNV is crucial for anyone concerned about their eye health. The condition can manifest in two forms: classic and occult.

1998年10月1日 · The report by Spaide et al 1 on the efficacy of external beam radiation using 1000 cGy and 5 fractions compares meaningfully large numbers of patients with subfoveal new vessels who had treatment or no treatment. If the groups are well matched, it is highly likely that radiation at this dosage at the best is ineffective and may in fact be harmful.

MICRON® Image-Guided Laser System produces precise, easy to deliver laser photocoagulation to generate choroidal neovascularization (CNV). A user-friendly design enables technical staff to precisely and reliably control the location, size, and intensity of the laser photocoagulation required for CNV.

拷贝数变异（CNV）在癌症的发生和发展研究中扮演重要的角色。 由于基因组重排（如染色体缺失、重复、插入和易位），导致染色体片段的扩增或删失。

Aims To evaluate safety and visual outcomes after proton beam irradiation (PBI) therapy for subfoveal choroidal neovascularisation (CNV) secondary to causes other than age-related macular degeneration (AMD).

2018年3月1日 · We report a case of macular hole that occurred after intravitreal injection of an anti-VEGF agent for age-related macular degeneration (AMD) in a patient, who underwent vitrectomy combined with choroidal neovascularization (CNV) removal. A 64-year-old female with AMD affecting her right eye received an intravitreal injection of an anti-VEGF agent.

CONCLUSIONS: PBI is a safe and efficacious treatment for subfoveal CNV not due to AMD. The data with respect to visual outcomes and radiation complications trend in favour of the 16 CGE group, although differences do not reach statistical significance. PBI may be considered as an alternative to current therapies.